Credit: K KStock/Adobe Stock

Novo Nordisk filed complaints this week against two pharmaceutical companies that are seeking approval to develop generic versions of its patented Wegovy product for weight loss.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Alexa Woronowicz

Alexa Woronowicz is chief copy editor for ALM and associate editor for The Legal Intelligencer. Contact her at [email protected] or on Twitter @AWoronowiczTLI.